Impact of a pharmacist-based multidimensional intervention aimed at decreasing the risk of hyperkalemia in heart failure patients: A Latin-American experience
- 1 April 2021
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 329, 136-143
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Review of the Role of the Pharmacist in Heart Failure Transition of CareAdvances in Therapy, 2018
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Serum potassium levels as an outcome determinant in acute medical admissionsClinical Medicine, 2015
- A New Era for the Treatment of Hyperkalemia?New England Journal of Medicine, 2015
- Risk Factors for Hyperkalaemia in a Cohort of Patients with Newly Diagnosed Heart Failure: A Nested Case–Control Study in UK General PracticeEuropean Journal of Heart Failure, 2015
- The Reality of Heart Failure in Latin AmericaJACC, 2013
- Regularization Parameter Selections via Generalized Information CriterionJournal of the American Statistical Association, 2010
- Hyperkalemia: A ReviewJournal of Intensive Care Medicine, 2005
- Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA StudyAIDS, 2002
- Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter studyJACC, 2000